These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20368343)

  • 1. Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.
    Sakthianandeswaren A; Curtis JM; Elso C; Kumar B; Baldwin TM; Lopaticki S; Kedzierski L; Smyth GK; Foote SJ; Handman E
    Infect Immun; 2010 Jun; 78(6):2734-44. PubMed ID: 20368343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection.
    Roberts LJ; Baldwin TM; Speed TP; Handman E; Foote SJ
    Eur J Immunol; 1999 Sep; 29(9):3047-50. PubMed ID: 10508279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.
    Castellucci L; Jamieson SE; Miller EN; de Almeida LF; Oliveira J; Magalhães A; Guimarães LH; Lessa M; Lago E; de Jesus AR; Carvalho EM; Blackwell JM
    Genes Immun; 2011 Oct; 12(7):589-94. PubMed ID: 21633373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
    Elso C; Kumar B; Smyth G; Foote S; Handman E
    Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice.
    Beebe AM; Mauze S; Schork NJ; Coffman RL
    Immunity; 1997 May; 6(5):551-7. PubMed ID: 9175833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection.
    Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E
    Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9.
    Roberts LJ; Baldwin TM; Curtis JM; Handman E; Foote SJ
    J Exp Med; 1997 May; 185(9):1705-10. PubMed ID: 9151907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice.
    Vladimirov V; Badalová J; Svobodová M; Havelková H; Hart AA; Blazková H; Demant P; Lipoldová M
    Infect Immun; 2003 Apr; 71(4):2041-6. PubMed ID: 12654824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
    Almeida L; Silva JA; Andrade VM; Machado P; Jamieson SE; Carvalho EM; Blackwell JM; Castellucci LC
    Infect Genet Evol; 2017 Apr; 49():212-220. PubMed ID: 28119029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 is a susceptibility factor for Leishmania major infection.
    Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
    J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With
    Kauffmann F; Meert E; de Jonge K; Elkrim Y; Hanot Mambres D; Denis O; Muraille E; Magez S; De Trez C
    Front Immunol; 2018; 9():503. PubMed ID: 29593739
    [No Abstract]   [Full Text] [Related]  

  • 14. A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus.
    Baguet A; Epler J; Wen KW; Bix M
    J Exp Med; 2004 Dec; 200(12):1605-12. PubMed ID: 15596523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.
    Blackwell JM; Black GF; Peacock CS; Miller EN; Sibthorpe D; Gnananandha D; Shaw JJ; Silveira F; Lins-Lainson Z; Ramos F; Collins A; Shaw MA
    Philos Trans R Soc Lond B Biol Sci; 1997 Sep; 352(1359):1331-45. PubMed ID: 9355125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice.
    Mock B; Blackwell J; Hilgers J; Potter M; Nacy C
    Eur J Immunogenet; 1993 Oct; 20(5):335-48. PubMed ID: 9098402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice.
    Badalová J; Svobodová M; Havelková H; Vladimirov V; Vojtísková J; Engová J; Pilcík T; Volf P; Demant P; Lipoldová M
    Genes Immun; 2002 Jun; 3(4):187-95. PubMed ID: 12058253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
    Barbi J; Brombacher F; Satoskar AR
    J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.
    Nabors GS; Farrell JP
    Infect Immun; 1994 Sep; 62(9):3655-62. PubMed ID: 8063382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.